Literature DB >> 23725608

Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults.

Joana Bastos1, Bárbara Peleteiro, Rita Barros, Luís Alves, Milton Severo, Maria de Fátima Pina, Hugo Pinto, Sandra Carvalho, Ana Marinho, João T Guimarães, Ana Azevedo, Carlo La Vecchia, Henrique Barros, Nuno Lunet.   

Abstract

BACKGROUND: Understanding the determinants of Helicobacter pylori infection in adults is essential to predict the burden of H. pylori-related diseases. We aimed to estimate the prevalence and incidence of H. pylori infection and to identify its major sociodemographic correlates in an urban population from the North of Portugal.
MATERIAL AND METHODS: A representative sample of noninstitutionalized adult inhabitants of Porto (n = 2067) was evaluated by ELISA (IgG) and a subsample (n = 412) was tested by Western Blot to assess infection with CagA-positive strains. Modified Poisson and Poisson regression models were used to estimate crude and sex-, age-, and education-adjusted prevalence ratios (PR) and incidence rate ratios (RR), respectively.
RESULTS: The prevalence of H. pylori infection was 84.2% [95% confidence interval (95%CI): 82.4-86.1]. It increased across age-groups in the more educated subjects, (18-30 years: 72.6%; ≥71 years: 88.1%; p for trend <0.001) and decreased with education in the younger (≤4 schooling years: 100.0%; ≥10 schooling years: 72.6%; p for trend <0.001). Living in a more deprived neighborhood was associated with a higher prevalence of infection, only in the younger (PR = 1.20, 95%CI: 1.03-1.38) and more educated participants (PR = 1.15, 95%CI: 1.03-1.29). Among the infected, the proportion with CagA-positive strains was 61.7% (95%CI: 56.6-66.9). The incidence rate was 3.6/100 person-years (median follow-up: 3 years; 95%CI: 2.1-6.2), lower among the more educated (≥10 vs ≤9: RR = 0.25, 95%CI: 0.06-0.96). The seroreversion rate was 1.0/100 person-years (95%CI: 0.6-1.7).
CONCLUSIONS: The prevalence of infection among adults is still very high in Portugal, suggesting that stomach cancer rates will remain high over the next few decades.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter pylori infection; Portugal; incidence; prevalence

Mesh:

Year:  2013        PMID: 23725608     DOI: 10.1111/hel.12061

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  19 in total

Review 1.  An Overview of Helicobacter pylori Infection.

Authors:  Rebecca FitzGerald; Sinéad M Smith
Journal:  Methods Mol Biol       Date:  2021

2.  Guidelines in Gastroenterology: Careful Interpretation Is Essential.

Authors:  Catarina Correia; Nuno Almeida; Pedro Narra Figueiredo
Journal:  GE Port J Gastroenterol       Date:  2021-08-25

Review 3.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

4.  A comparative proteomic approach using metabolic pathways for the identification of potential drug targets against Helicobacter pylori.

Authors:  Reaz Uddin; Waqar Khalil
Journal:  Genes Genomics       Date:  2020-03-19       Impact factor: 1.839

5.  Sodium intake and Helicobacter pylori infection in the early stages of life.

Authors:  Catarina Monteiro; Ana Rute Costa; Bárbara Peleteiro
Journal:  Porto Biomed J       Date:  2016-06-17

6.  The prevalence of Helicobacter pylori is decreasing in Iranian patients.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Mahsa Molaei; Hajar Taslimi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?

Authors:  Nuno Almeida; Maria Manuel Donato; José Manuel Romãozinho; Cristina Luxo; Olga Cardoso; Maria Augusta Cipriano; Carol Marinho; Alexandra Fernandes; Carlos Calhau; Carlos Sofia
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

Review 8.  Novel Idea: Virulence-Based Therapy Against Helicobacter pylori Infection (Smart Therapy).

Authors:  Amin Talebi Bezmin Abadi
Journal:  Front Med (Lausanne)       Date:  2014-06-23

9.  Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery.

Authors:  Cátia Arieira; Pedro Boal Carvalho; Francisca Dias de Castro; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2019-02-07

10.  Association between Helicobacter pylori and Serum Leptin in Iranian Dyspeptic Patients.

Authors:  Gholamreza Hemmasi; Farhad Zamani; Mahmoodreza Khonsari; Masoudreza Sohrabi; Nafiseh Abdollahi; Hossein Ajdarkosh
Journal:  Middle East J Dig Dis       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.